Sign In
Buy BEAT
$0.710
-0.0495 (-6.52%)
At Close: Jun 22, 2026
BIOTELEMETRY ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of BEAT and Encourages Investors to Contact the Firm
03:30pm, Friday, 18'th Dec 2020
NEW YORK, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of BioTelemet
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of BioTelemetry, Inc.
02:17pm, Friday, 18'th Dec 2020
NEW YORK, Dec. 18, 2020 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by BioTelemetry, Inc. (NASDAQ: BEAT) and its board of directors concerning the proposed acq
BioTelemetry soars 18% after Philips announces acquisition of cardiac-diagnostics company
02:04pm, Friday, 18'th Dec 2020
BioTelemetry gained as much as 18% on Friday after news that the cardiac-diagnostics firm will be acquired by Dutch company Royal Philips for $2.8 billion. BioTelemetry is a Pennsylvania-based medical
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of BioTelemetry, Inc. (NASDAQ: BEAT) to Royal Philips for $72.00 per share in cash is
(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price?
08:51am, Friday, 18'th Dec 2020
SAN DIEGO, Dec. 18, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of BioTelemetry, Inc. (NASDAQ: BEAT) breached thei
Philips to Acquire BioTelemetry
02:51am, Friday, 18'th Dec 2020
MALVERN, Pa., Dec. 18, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT) , the leading remote medical technology company focused on the delivery of health information to improve quality of li
BioTelemetry Has Sequential Upside Via Double-Digit Growth Into 2021
11:38am, Tuesday, 17'th Nov 2020
BioTelemetry has had a better than expected third quarter, leveraging new patient uptake plus clinician accounts in their healthcare and continuous care segments. Management have secured better lendin
BioTelemetry's (BEAT) CEO Joseph Capper on Q3 2020 Results - Earnings Call Transcript
11:54pm, Thursday, 29'th Oct 2020
BioTelemetry's (BEAT) CEO Joseph Capper on Q3 2020 Results - Earnings Call Transcript
BioTelemetry, Inc. Reports Third Quarter 2020 Financial Results
04:05pm, Thursday, 29'th Oct 2020
Posts Record Quarterly Revenue Amidst Rapid Recovery Posts Record Quarterly Revenue Amidst Rapid Recovery
Global Telehealth Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2020-2024
12:00am, Tuesday, 13'th Oct 2020
Telehealth market will register an incremental spend of about $11 billion, growing at a CAGR of 26.19% during the five-year forecast period.
The
Oct 07, 2020 (The Expresswire) --
Global "Mobile Health App Market" 2020: - Mobile Health App Market report intends to offer inside and out data about Mobile...
$46.2 Billion Connected Medical Devices - Global Market Trajectory & Analytics to 2027 - ResearchAndMarkets.com
12:00am, Friday, 02'nd Oct 2020
The
Financial Contrast: Aesthetic Medical International Holdings Group (NASDAQ:AIH) versus BioTelemetry (NASDAQ:BEAT)
01:44am, Monday, 28'th Sep 2020
Aesthetic Medical International Holdings Group (NASDAQ:AIH) and BioTelemetry (NASDAQ:BEAT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based
Stifel Financial Corp Has $1.13 Million Stock Position in BioTelemetry Inc (NASDAQ:BEAT)
05:04am, Thursday, 24'th Sep 2020
Stifel Financial Corp lifted its stake in BioTelemetry Inc (NASDAQ:BEAT) by 25.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange C
